OK
Oklahoma Senate Bill SR2

Oklahoma 2025 Regular Session

Oklahoma Senate Bill SR2 Compare Versions

OldNewDifferences
11
22
33
4-Resolution
5-ENROLLED SENATE
6-RESOLUTION NO. 2 By: Rader, Alvord, Bergstrom,
7-Boren, Brooks, Bullard,
8-Burns, Coleman, Daniels,
9-Deevers, Dossett, Frix,
10-Gillespie, Gollihare,
11-Goodwin, Green, Grellner,
12-Guthrie, Hall, Hamilton,
13-Haste, Hicks, Hines,
14-Howard, Jech, Jett, Kern,
15-Kirt, Mann, McIntosh,
16-Murdock, Nice, Paxton,
17-Pederson, Prieto, Pugh,
18-Reinhardt, Rosino,
19-Sacchieri, Seifried,
20-Standridge, Stanley,
21-Stewart, Thompson, Weaver,
22-Wingard, and Woods
4+Req. No. 1777 Page 1 1
5+2
6+3
7+4
8+5
9+6
10+7
11+8
12+9
13+10
14+11
15+12
16+13
17+14
18+15
19+16
20+17
21+18
22+19
23+20
24+21
25+22
26+23
27+24
28+ 1
29+2
30+3
31+4
32+5
33+6
34+7
35+8
36+9
37+10
38+11
39+12
40+13
41+14
42+15
43+16
44+17
45+18
46+19
47+20
48+21
49+22
50+23
51+24
52+
53+STATE OF OKLAHOMA
54+
55+1st Session of the 60th Legislature (2025)
56+
57+SENATE
58+RESOLUTION 2 By: Rader
2359
2460
61+
62+
63+AS INTRODUCED
2564
2665 A Resolution declaring the fourth Wednesday in
2766 February of each year as Hypertrophic Cardiomyopathy
2867 Awareness Day; acknowledging the im portance of
2968 hypertrophic cardiomyopathy (HCM) awareness to
3069 improve cardiovascular health; supporting awareness
3170 of the consequences of untreated HCM and the need to
3271 seek appropriate care; requesting the Governor to
3372 annually issue a proclamation recognizing
3473 Hypertrophic Cardiomyopathy Awareness Day ; and
3574 calling upon the people of this sta te to observe the
3675 day.
3776
3877
3978
4079 WHEREAS, hypertrophic cardiomyopathy (HCM) is a chronic cardiac
4180 disease involving the thickening of the heart muscle that can
4281 potentially lead to debilitating symptoms and serious complications ,
4382 including heart failure, atrial fibrillation, stroke, and in rare
4483 cases sudden cardiac death; and
45-
46-
47-
48-ENR. S. R. NO. 2 Page 2
4984 WHEREAS, HCM is the most common inheritable heart disease and
5085 can affect anyone regardless of age, gend er, or ethnicity with a
5186 reported prevalence ranging from one in 200 to one in 500 in the
5287 general population; and
53-
5488 WHEREAS, an estimated 700,000 to 1,650,000 people in the United
5589 States have HCM, yet 85% of them may remain undiagnosed; and
90+
91+
92+Req. No. 1777 Page 2 1
93+2
94+3
95+4
96+5
97+6
98+7
99+8
100+9
101+10
102+11
103+12
104+13
105+14
106+15
107+16
108+17
109+18
110+19
111+20
112+21
113+22
114+23
115+24
116+ 1
117+2
118+3
119+4
120+5
121+6
122+7
123+8
124+9
125+10
126+11
127+12
128+13
129+14
130+15
131+16
132+17
133+18
134+19
135+20
136+21
137+22
138+23
139+24
56140
57141 WHEREAS, HCM shares symptoms with other common cardiovascular
58142 and pulmonary diseases, such as shortness of breath, chest pain,
59143 fatigue, palpitations, and fainting, making it difficult to
60144 distinguish HCM from other diseases; and
61-
62145 WHEREAS, when untreated, the all-cause mortality risk is three
63146 to four times higher in patients with HCM than that of the genera l
64147 population; and
65-
66148 WHEREAS, knowing one’s medical history and any signs and
67149 symptoms of HCM is an important first step in receiving an accurate
68150 diagnosis of HCM; and
69-
70151 WHEREAS, a health care provider must conduct a thorough
71152 screening with cardiac health questions to help identify a risk of
72153 cardiac disorders, both genetic and congenital; and
73-
74154 WHEREAS, a health care provider may conduct several tests,
75155 including an echocardiogram, a cardiac MRI, or genetic testing to
76156 confirm a family history of HCM, and must exami ne the heart to
77157 diagnose HCM; and
78-
79158 WHEREAS, following a diagnosis of HCM, it is important for the
80159 patient to work with his or her health care provider to learn more
81160 about the disease and understand different management options,
82161 including prescription medicines and surgical treatment s that may
83162 help; and
84-
85163 WHEREAS, the fourth Wednesday in February is an appropriate day
86164 to observe Hypertrophic Cardiomyopathy Awareness Day.
87165
166+
167+Req. No. 1777 Page 3 1
168+2
169+3
170+4
171+5
172+6
173+7
174+8
175+9
176+10
177+11
178+12
179+13
180+14
181+15
182+16
183+17
184+18
185+19
186+20
187+21
188+22
189+23
190+24
191+ 1
192+2
193+3
194+4
195+5
196+6
197+7
198+8
199+9
200+10
201+11
202+12
203+13
204+14
205+15
206+16
207+17
208+18
209+19
210+20
211+21
212+22
213+23
214+24
215+
88216 NOW, THEREFORE, BE IT RESOLVED BY THE SENATE OF THE 1ST SESSION
89217 OF THE 60TH OKLAHOMA LEGISLATURE:
90-
91-
92-
93-ENR. S. R. NO. 2 Page 3
94218 THAT the Senate declares the fourth Wednesday in February of
95219 each year as Hypertrophic Cardiomyopathy Awareness Day in the State
96220 of Oklahoma in order to raise public a wareness about HCM.
97-
98221 THAT the Senate acknowledges the critical importance of HCM
99222 awareness to improve cardiovascular health in this state.
100-
101223 THAT the Senate supports raising awareness of the consequences
102224 of undiagnosed and untreated HCM and the need to seek a ppropriate
103225 care for HCM as a serious public health issue.
104-
105226 THAT the Senate respectfully requests the Governor to annually
106227 issue a proclamation recognizing the fourth Wednesday in February as
107228 Hypertrophic Cardiomyopathy Awareness Day in the State of Oklahoma
108229 and calls upon the people of this state to observe the day with
109230 appropriate programs and activities.
110231
111-Adopted by the Senate the 26th day of February, 2025.
112-
113-
114-
115- Presiding Officer of the Senat e
116-
117-OFFICE OF THE SECRETARY OF STATE
118-Received by the Office of the Secretary of State this _______ ___
119-day of _________________ _, 20 _______, at _______ o'clock ___ ____ M.
120-By: _________________________________
232+60-1-1777 DC 2/25/2025 1:33:19 PM